Displaying 1–25 of 10643 results for
A new and weird rumor has surfaced in the anti-vaccine movement: potatoes can suck the toxins from vaccines out of your kids' arms.
A lower dose of non-opioid painkiller, tanezumab, developed by Pfizer and Eli Lilly failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoarthritis.
The Amgen Foundation has teamed with the University of South Florida to launch the Amgen Biotech Experience (ABE) program, designed to give students hands-on biotechnology lab experience.
The biggest case of fraud in biotech history is getting its day in the spotlight.
At least 10 people have died from smoke inhalation at a manufacturing plant in China owned by a large pharmaceutical company.
The FDA has issued a warning letter to RIJ Pharmaceutical following an inspection that uncovered unacceptable levels of three bacteria in water used in operations.
What effects do X-ray inspection have on active pharmaceutical ingredient quality?
Gilead is paying insitro $15 million upfront with additional near-term payments up to $35 million based on operational milestones.
If approved this will have the drugmaker go head to head against Roche’s Lucentis and Regeneron’s Eylea.
The U.S. Supreme Court has rejected Allergan’s attempt to protect drug patents by transferring them a Native American tribe.
Contract drug manufacturer Catalent has agreed to acquire Paragon Bioservices for in $1.2 billion in cash, to help expand its gene-therapy manufacturing capabilities.
EIP Pharma, a central nervous system-focused therapeutics company, announced the successful completion of $11.2 million in new private funding to explore the use of an investigational drug as a treatment for dementia with Lewy bodies and for the cognitive deficits in Huntington's disease.
The European Medicines Agency is taking a closer look at safety issues linked to the use of a Sanofi multiple sclerosis drug, Lemtrada.
Joe Biden addressed a sold-out audience at University of Pennsylvania, joining a panel conversation about the opioid crisis.
Bristol-Myers Squibb shareholders approved the company’s $74 billion acquisition of rival Celgene, despite activist campaigns to break up the deal.
The US FDA announced that women taking Sprout Pharma's female libido pill, Addyi, do not need to completely avoid alcohol.
Despite negative public opinions and heavy demands, survey respondents indicate rising satisfaction and pride in their work
The FDA has greenlighted Amgen’s new osteoporosis drug for postmenopausal women
Federal prosecutors with the Department of Justice have indicted Indivior for what they call a multibillion-dollar scheme to ratchet up sales of an opioid addiction treatment.
The U.S. Food and Drug Administration, after a preliminary review, cited a lack of certain non-clinical studies to assess the chronic administration of fenfluramine and due to an incorrect dataset.
ViiV is GSK’s HIV drugs division where Pfizer and Shionogi & Co have stakes as well.
Acidic liquids could cause damage to equipment over time through corrosion, which will result in costly breakdowns and downtime without sufficient preventive measures.
Celgene and Acceleron Pharma announced that Celgene has submitted a Biologics License Application (BLA) for one of the drugmaker's most promising experimental blood disease drugs.
Nearly a year and a half after the death of Apotex’s founder and CEO and his wife, the company is reportedly mulling a sale.